Macrophage migration inhibitory factor gene promoter polymorphism (-173G/C SNP) determines host susceptibility and

Krishnamoorthi Sumaiya1, Kalimuthusamy Natarajaseenivasan1

  • 1Medical Microbiology Laboratory, Department of Microbiology, Centre for Excellence in Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

Microbial Pathogenesis
|February 13, 2022
PubMed

Insights

The macrophage migration inhibitory factor (MIF) -173G/C gene polymorphism is linked to leptospirosis. Specific genotypes (GC and CC) increase susceptibility and severity of this infectious disease.

Area of Science:

  • Genetics and Immunology
  • Infectious Diseases

Background:

  • Leptospirosis severity mechanisms are not fully understood.
  • Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine linked to inflammatory disease risk and severity.

Purpose of the Study:

  • To investigate the association between macrophage migration inhibitory factor (MIF) gene promoter polymorphisms and susceptibility to, as well as severity of, human leptospirosis.
  • To analyze the relationship between MIF gene polymorphisms, MIF expression, and inflammatory cytokine profiles in leptospirosis patients.

Main Methods:

  • Analysis of MIF -173G/C single nucleotide polymorphism (SNP) using PCR-RFLP.
  • Quantification of MIF mRNA and serum levels via quantitative real-time PCR and ELISA.
  • Assessment of inflammatory cytokine expression (TNF-α, IL-1β, IL-4, IL-10).

Main Results:

  • MIF -173G/C polymorphism, particularly the -173*C allele, is significantly associated with increased susceptibility (GC genotype) and severity (CC genotype) of leptospirosis.
  • Carriers of risk genotypes (GC and CC) exhibited significantly elevated serum MIF levels and increased MIF mRNA expression.
  • High MIF expression correlated with upregulated TNF-α, IL-1β, and IL-4, and downregulated IL-10 mRNA expression.

Conclusions:

  • The MIF -173G/C polymorphism is a significant genetic factor influencing both susceptibility and severity in human leptospirosis.
  • MIF -173G/C genotypes may serve as potential biomarkers for predicting leptospirosis risk and disease progression.